Fast-Track Approval Strategies for Ultra-Rare Diseases
Fast-Track Approval Strategies for Ultra-Rare Diseases Regulatory Strategies to Accelerate Approval for Ultra-Rare Disease Therapies Understanding the Unique Challenges of Ultra-Rare Disease Trials Ultra-rare diseases, often defined as conditions affecting fewer than 1 in 50,000 people, present major challenges to traditional drug development. With extremely small patient populations, high unmet medical need, and often limited…
Read More “Fast-Track Approval Strategies for Ultra-Rare Diseases” »